Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor

The CardioMEMS™ Hf System Is The First and Only FDA-Approved Heart Failure Monitor Proven to Significantly Reduce Heart Failure Hospital Admissions and Improve Quality of Life New Study Will Evaluate Whether Treatment with the CardioMEMS Monitor Improve... Devices, Monitoring, Cardiology Abbott, CardioMEMS, GUIDE-HF trial, heart failure, pulmonary artery pressure
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news